NasdaqGS - Nasdaq Real Time Price USD

Sotera Health Company (SHC)

11.40

+0.08

(+0.71%)

At close: April 26 at 4:00 PM EDT

11.40

0.00

(0.00%)

After hours: April 26 at 4:20 PM EDT

Sotera Health Announces First-Quarter 2024 Earnings Release Date

CLEVELAND, April 11, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first-quarter ended March 31, 2024 before the market opens on Thursday, May 2, 2024. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s oper

GlobeNewswire 17 days ago
Sotera Health Announces Pricing of Secondary Offering

CLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share, at a price to the public of $14.75 per share. All 25,000,000 shares are being offered by selling stockholders, which include certain affiliates of Warburg Pincus LLC and GTCR LLC, as well as two members of management and one member of the Board of Directors of th

GlobeNewswire last month
Sotera Health Announces Secondary Offering of Common Stock

CLEVELAND, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share. All 25,000,000 shares are being offered for sale by selling stockholders, which include affiliates of Warburg Pincus LLC and GTCR, LLC, as well as two members of management and one member of the Board of Directors of the Company. In addition, the selling stockholders have granted

GlobeNewswire last month
Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook

2023 net revenues increased 4.5% to $1.05 billion, compared to 20222023 net income of $51 million or $0.18 per diluted share2023 Adjusted EBITDA(1) increased 4.3% to $528 million2023 Adjusted EPS(1) decreased $0.15 to $0.81 per diluted shareFull-year 2024 outlook of 4.0% - 6.0% growth for Net Revenues and Adjusted EBITDA CLEVELAND, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end ste

GlobeNewswire last month
Sotera Health Announces Fourth-Quarter and Full-Year 2023 Earnings Release Date

CLEVELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2023 before the market opens on Tuesday, February 27, 2024. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to disc

GlobeNewswire 2 months ago
Sotera Health Chairman and CEO Presents at 42nd Annual J.P. Morgan Healthcare Conference

CLEVELAND, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, is presenting today at the 42nd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business. “I am pleased to announce that Sotera H

GlobeNewswire 3 months ago
Sotera Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference

CLEVELAND, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15 pm Eastern. Mr. Petras, Jon Lyons, Senior Vice President and CFO, and Jason

GlobeNewswire 3 months ago
Sotera Health Appoints Karen Flynn to Board of Directors

CLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Karen Flynn as a new independent director to its Board. Ms. Flynn is an accomplished healthcare leader with over 35 years of commercial, operations and general management experience in the pharmaceutical services industry. She most recen

GlobeNewswire 5 months ago
Sotera Health Reports Third-Quarter and Year-to-Date 2023 Results

Q3 2023 net revenues of $263 million increased 6%, compared to Q3 2022Q3 2023 net loss of $14 million or $0.05 per diluted share, compared to net income of $25 million or $0.09 per diluted share in Q3 2022 Q3 2023 Adjusted EBITDA of $134 million increased 7%, compared to Q3 2022Q3 2023 Adjusted EPS of $0.21 decreased $0.02 per diluted share, compared to Q3 2022 driven by higher interest expenseCompany reaffirms 2023 outlook, anticipates results at the lower end of the range CLEVELAND, Nov. 01, 2

GlobeNewswire 5 months ago
Sotera Health Announces Third-Quarter 2023 Earnings Release Date

CLEVELAND, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third-quarter ended September 30, 2023 before the market opens on Wednesday, November 1, 2023. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Compa

GlobeNewswire 6 months ago
Sotera Health Reports Second-Quarter and First-Half 2023 Results

Q2 2023 net revenues of $255 million decreased 4%, compared to Q2 2022, primarily driven by expected Nordion Cobalt-60 harvest schedule timingQ2 2023 net income of $24 million or $0.08 per diluted share, compared to net income of $30 million or $0.11 per diluted share in Q2 2022Q2 2023 Adjusted EBITDA of $128 million decreased 6%, compared to Q2 2022, driven by expected Nordion Cobalt-60 harvest schedule timingQ2 2023 Adjusted EPS of $0.21 decreased $0.06 per diluted share, compared to Q2 2022 T

GlobeNewswire 8 months ago
Sotera Health Announces Second-Quarter 2023 Earnings Release Date

CLEVELAND, July 18, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2023 before the market opens on Thursday, August 3, 2023. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s op

GlobeNewswire 9 months ago
Sotera Health Announces Jon Lyons as New Senior Vice President and Chief Financial Officer

CLEVELAND, June 26, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced that Jon Lyons has joined the Company, effective today, as Senior Vice President and Chief Financial Officer (“CFO”). Mr. Lyons recently served as Vice President, Corporate FP&A for Owens Corning (NYSE: OC), a nearly $10 billion global building and constructio

GlobeNewswire 9 months ago
Sotera Health Finalizes Settlement of Ethylene Oxide Litigation in Illinois

99.7% of eligible claimants agree to participate in settlementCLEVELAND, June 22, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (“The Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced that the opt-in process for the January 2023 settlements of ethylene oxide claims against Sterigenics in the Circuit Court of Cook County, Illinois is complete and Sterigenics

GlobeNewswire 10 months ago
Sotera Health to Present at the 2023 RBC Capital Markets Global Healthcare Conference

CLEVELAND, May 12, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will participate in an open forum discussion at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023 at 4:35 pm Eastern. Sotera Health management wi

GlobeNewswire 11 months ago
Sotera Health Reports First-Quarter 2023 Results

Q1 2023 net revenues of $221 million decreased 7%, compared to Q1 2022, primarily driven by Nordion Cobalt-60 harvest schedule timing, as expectedQ1 2023 net income of $3 million or $0.01 per diluted share, compared to net income of $31 million or $0.11 per diluted share in Q1 2022Q1 2023 Adjusted EBITDA of $98 million decreased 15%, compared to Q1 2022, driven by Nordion Cobalt-60 harvest schedule timing, as expectedQ1 2023 Adjusted EPS of $0.13 decreased by $0.09 per diluted share, compared to

GlobeNewswire 11 months ago

Performance Overview

Return	SHC	S&P 500
YTD	-32.34%	+6.92%
1-Year	-30.57%	+25.26%
3-Year	-55.69%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Sotera Health Company (SHC)

Sotera Health Announces First-Quarter 2024 Earnings Release Date

Sotera Health Announces Pricing of Secondary Offering

Sotera Health Announces Secondary Offering of Common Stock

Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook

Sotera Health Announces Fourth-Quarter and Full-Year 2023 Earnings Release Date

Sotera Health Chairman and CEO Presents at 42nd Annual J.P. Morgan Healthcare Conference

Sotera Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Sotera Health Appoints Karen Flynn to Board of Directors

Sotera Health Reports Third-Quarter and Year-to-Date 2023 Results

Sotera Health Announces Third-Quarter 2023 Earnings Release Date

Sotera Health Reports Second-Quarter and First-Half 2023 Results

Sotera Health Announces Second-Quarter 2023 Earnings Release Date

Sotera Health Announces Jon Lyons as New Senior Vice President and Chief Financial Officer

Sotera Health Finalizes Settlement of Ethylene Oxide Litigation in Illinois

Sotera Health to Present at the 2023 RBC Capital Markets Global Healthcare Conference

Sotera Health Reports First-Quarter 2023 Results

Performance Overview